trending Market Intelligence /marketintelligence/en/news-insights/trending/poedyxymp7maykilqvgmda2 content esgSubNav
In This List

AbbVie enters $3B credit agreement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


AbbVie enters $3B credit agreement

AbbVie Inc. entered a credit agreement for a $3 billion unsecured revolving credit facility.

Borrowings under the agreement may, at AbbVie's election, bear interest at the base rate plus an applicable margin of 0.000% to 0.325% per annum, or the Eurocurrency rate plus an applicable margin of 0.700% to 1.325% per annum.

Additionally, the North Chicago, Ill.-based drugmaker repaid all outstanding obligations and terminated all outstanding commitments under a revolving credit agreement dated Aug. 18, 2014. The agreement was also for a $3 billion unsecured revolving credit facility.

JPMorgan Chase Bank, N.A. acted as administrative agent for both credit agreements.